The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes proposed by the Central Government, anchored on section 159 of the Patents Act, 1970. The government seeks to amend the …
Despite large gains in health over the past few decades, the distribution of health risks worldwide remains extremely and unacceptably uneven. Although the health sector has a crucial role in addressing health inequalities, its efforts often come into conflict with powerful global actors in pursuit of other interests such as …
The Indian pharmaceutical company has been built from an industry that copies patent drugs and manufactures them inexpensively. Now it is counted amongst the industries that are fuelling India‘s economic growth and holds enormous potential. Indian-based pharmaceutical companies are also predicted to gain considerable market share in the world. It …
As the effective application of new technologies has become increasingly important to most nations’ economic growth and development, the significance of intellectual property (IP) rights has also increased. Most technological innovations come from the world’s most advanced countries; and the transfers of those technologies to developing nations, mostly through the …
The second edition of the GIPC International IP Index, entitled Charting the Course, is a snapshot of where 25 countries’ IP environments are today, and can help provide a road map for those countries wanting to improve their IP environment. This year’s Index builds upon the inaugural edition, Measuring Momentum, …
Judgement of the Delhi High Court in the matter of Bristol Myers Squibb Company & Others Vs. V.C. Bhutada & Others dated 11/10/2013 regarding infringement of Indian patent No. 203937 and damages, rendition of accounts and delivery up. Original Source: http://lobis.nic.in/dhc/SMD/judgement/11-10-2013/SMD11102013IA104032013.pdf
Industrialised countries should phase out HFC says Sunita Narain, Director-General, CSE in this presentation at CSE Annual South Asian Media Briefing Workshop on Climate Change, 2013 held from September 18-19, 2013. HFC: A lesson on how companies make money to save the world - Presentation by Sunita Narain, Director-General, CSE …
Order of the High Court of Delhi on infringement of copyright, rendition of accounts of profits, damages, cost and delivery up of infringing goods dated 13/09/2013.
Judgement of the Supreme Court of India in the matter of Commissioner of Central Excise, Thane-II Vs M/s. Time Pharma, Mumbai dated 14/08/2013 regarding pharmaceutical products for the purposes of Central Excise tariff.
This is the first judgement citing Section 3(j) that says plants & animals aren’t patentable India’s patent appeals board has denied Monsanto a patent for a genetically-engineered method of increasing climate resilience in plants. The decision is significant not only for Monsanto’s loss of possible exclusivity in an increasingly important …
Pashmina, popularly known as 'Cashmere' is well known for its fineness, warmth, softness, desirable aesthetic value, elegance and timelessness in fashion. It is most luxurious, softer and warmer than superfine merino wool. India produces abouut 40-50 tonnes of fibre annually.
Drugs (Prices Control) Order, 2013 has directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations and it states that the Government may, - with a view to achieve adequate availability and to regulate the distribution of drugs, in case of emergency or in circumstances of urgency or …
It's double trouble for global pharma companies in India. On April 1, a Supreme Court bench comprising Judges Aftab Alam and Ranjana Desai dismissed Swiss drug major Novartis AG's seven-year-old plea seeking patent protection for its blood cancer drug Imatinib Mesylate, sold as Glivec. The court held that Glivec was …
The Pharmaceutical Research and Manufacturers of America and the United States India Business Council are miffed over the recent Novartis judgment of the Supreme Court (SC) of India. For us, however, this ruling on the question of the patentability of the beta crystalline form of Imatinib Mesylate (IM) is one …
The Supreme Court will pronounce on Monday its verdict in a landmark patent case involving Swiss pharma giant Novartis AG. The company has challenged the denial of patent to its blood cancer drug Glivec in India The verdict, which is crucial even for public health, is being watched closely by …
Supreme Court judgement dated 01-04-2013:in Appeal Civil No. 2706-2716/2013 @ SLP(C) 20539-20549/2009 Novartis AG Vs. Union of India and ors (Patent/Cancer Drug).
A technology called a ‘terminator’ was never going to curry much favour with the public. But even Monsanto, the agricultural biotechnology giant in St Louis, Missouri, was surprised by the furore that followed when it patented a method for engineering transgenic crops to produce sterile seed, forcing farmers to buy …
Vernon Hugh Bowman, a 75-year old Indiana farmer, says that switching to Monsanto Inc.'s "Roundup Ready" soybeans "made things so much simpler and better." Monsanto's patented beans can survive when they are sprayed with the herbicide glyphosate, also known as Roundup, which makes pest control much easier. Monsanto is less …
A freewheeling and almost entirely one-sided argument at the Supreme Court on Tuesday indicated that the justices would not allow Monsanto’s patents for genetically altered soybeans to be threatened by an Indiana farmer who used them without paying the company a fee. Monsanto’s patented Roundup Ready soybeans are resistant to …
There is something that Prime Minister Manmohan Singh has in common with US diplomats—or at least the intellectual property (IP) attachés posted at various diplomatic missions: a dislike of NGOs. Both, the leader of the world’s most populous democracy and the diplomats of the most powerful democracy, make no bones …
